CMPS

COMPASS Pathways Plc - American

4.56

Top Statistics
Market Cap 311 M Forward PE -2.20 Revenue Growth 0.00 %
Current Ratio 8.91 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -0.8940 Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 206 M Total Cash Per Share 3.02 Total Debt 32 M
Total Debt To Equity 16.86 Current Ratio 8.91 Book Value Per Share 2.82
All Measures
Short Ratio 319.00 % Message Board Id finmb_576453668 Shares Short Prior Month 5 M
Return On Equity -0.6468 City London Uuid b1fbf63a-9c13-3adb-8c90-e1d95306a599
Previous Close 4.52 First Trade Date Epoch Utc 1 B Book Value 2.82
Beta 2.30 Total Debt 32 M Volume 427633
Price To Book 1.62 Fifty Two Week Low 4.05 Total Cash Per Share 3.02
Shares Short Previous Month Date 1 B Target Median Price 17.00 Max Age 86400
Recommendation Mean 1.40 Sand P52 Week Change 0.3133 Target Mean Price 21.22
Net Income To Common -144322000 Short Percent Of Float 0.0729 Implied Shares Outstanding 68 M
Trailing Peg Ratio None Last Fiscal Year End 1 B Average Daily Volume10 Day 973510
Average Volume10days 973510 Total Cash 206 M Next Fiscal Year End 1 B
Held Percent Insiders 0.2215 Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 4.52 Target Low Price 12.00
Gmt Off Set Milliseconds -18000000 Fifty Day Average 5.74 Open 4.52
Free Cashflow -61139876 Dividend Yield 0.00 % Return On Assets -0.3522
Time Zone Short Name EST Trailing Eps -2.18 Day Low 4.48
Address1 33 Broadwick Street Shares Outstanding 68 M Price Hint 4
Target High Price 60.00 Website https://compasspathways.com 52 Week Change -0.2375
Average Volume 829003 Forward Eps -2.06 Recommendation Key strong_buy
Compensation As Of Epoch Date 1 B Quick Ratio 839.20 % Is_sp_500 False
Regular Market Day High 4.65 Profit Margins 0.00 % Debt To Equity 16.86
Fifty Two Week High 12.75 Day High 4.65 Shares Short 4 M
Regular Market Open 4.52 Industry Key medical-care-facilities Earnings Growth 0.00 %
Revenue Growth 0.00 % Shares Percent Shares Out 0.0610 Operating Cashflow -105211000
Currency USD Time Zone Full Name America/New_York Market Cap 311 M
Is_nasdaq_100 False Zip W1F 0DQ Quote Type EQUITY
Industry Medical Care Facilities Long Name COMPASS Pathways plc Regular Market Day Low 4.48
Held Percent Institutions 0.4836 Current Price 4.56 Enterprise To Ebitda -0.8940
Financial Currency USD Current Ratio 8.91 Industry Disp Medical Care Facilities
Number Of Analyst Opinions 9 Country United Kingdom Float Shares 43 M
Two Hundred Day Average 7.49 Enterprise Value 137 M Forward PE -2.20
Regular Market Volume 427633 Ebitda -153867008 Exchange NMS
Go to Yahoo Finance Go to Seeking Alpha
COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States.

It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa.

The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020.

COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.